Micropenis, Evaluation & Management
Stretched Penile Length Below -2.5 SD With Normal Anatomy, Endocrine and Surgical Workup
Evidence grade 4 of 5, Strong. Read how the Atlas grades evidence.
The written rationale for this grade is still being prepared.
- FDA
- Not applicable (clinical condition; hormonal and surgical management)
Reference only. Not medical advice.
What can go wrong
Untreated micropenis with an underlying endocrine disorder may signal broader hypothalamic-pituitary or gonadal pathology requiring management. Testosterone therapy in children must be carefully dosed and monitored to avoid premature bone maturation and virilization side effects. Psychological support is important. The diagnosis and treatment require specialist pediatric endocrine and urological care, not self-treatment or unregulated hormone use.
This is something to take to a clinician. The Atlas can tell you what is known about micropenis, evaluation & management in general. It cannot tell you what is happening in your body, and the difference matters most for exactly the symptoms that bring people to this page.
Micropenis is a precise clinical diagnosis: a normally formed penis with a stretched penile length more than 2.5 standard deviations below the mean for age, with no other genital ambiguity. Reference figures include roughly under 1.9 cm in a full-term newborn and under about 7 to 9 cm stretched in an adult. The cause is usually a hormonal defect of the hypothalamic-pituitary-gonadal axis arising late in fetal development: hypogonadotropic hypogonadism, primary (hypergonadotropic) testicular failure, or idiopathic. Evaluation is endocrine; first-line treatment in infancy or childhood is a course of testosterone (or gonadotropins) to stimulate penile growth. It is distinct from a normal-sized penis perceived as small and from a buried/concealed penis.
A specific clinical diagnosis, not a perception, defined by stretched length more than 2.5 SD below the mean.
What people take it for
What it is taken for. Approval, where it exists, covers only some of these.
- Endocrine evaluation
- Workup of the hypothalamic-pituitary-gonadal axis (gonadotropins, testosterone, sometimes hCG stimulation and genetic testing) to classify the cause and exclude a disorder of sex development.
- Testosterone therapy
- First-line in prepubertal children to stimulate penile growth; response is generally good for length, and treatment is time-limited and monitored.
- Gonadotropin therapy
- Considered in hypogonadotropic hypogonadism to stimulate testicular and penile development.
- Specialist multidisciplinary care
- When micropenis is part of a broader endocrine or DSD picture, care involves pediatric endocrinology, urology, and psychology.
- Surgical/andrologic options in adulthood
- Limited; addressed cautiously and individually when hormonal treatment in childhood was insufficient.
How it works
Testosterone acts on androgen receptors in penile tissue to stimulate growth; a short course of testosterone (commonly intramuscular esters or topical) in infancy or childhood is the standard first attempt to increase penile size, and many patients show meaningful growth. In hypogonadotropic cases, gonadotropin therapy can stimulate both the testes and penile growth. The androgen window for penile growth is greatest in early development, which is why evaluation and treatment are typically initiated in childhood.
The penis in micropenis is anatomically normal in form but small in dimension. Penile length is assessed as stretched penile length, measured from the pubic bone (compressing the suprapubic fat pad) to the tip of the glans, because stretched length correlates with erect length better than flaccid length. The diagnosis requires that internal and external genitalia are otherwise normal, distinguishing micropenis from disorders of sex development with genital ambiguity, and from a normal penis hidden by fat (buried penis) or webbing.
Safety in detail
Micropenis requires endocrine and urological evaluation by specialists; it may indicate an underlying hormonal disorder. Hormone therapy must be physician-directed and monitored, particularly in children, to avoid adverse effects on growth and development. Self-administered testosterone is not appropriate.
What people get wrong
Often saidAny small-looking penis is a micropenis
ActuallyMicropenis is a strict diagnosis based on stretched length more than 2.5 SD below the mean with otherwise normal anatomy. Most men who perceive themselves as small fall within the normal range, and fat or webbing can hide a normal penis (buried penis).
Often saidTestosterone in adulthood will fix micropenis
ActuallyThe androgen-responsive growth window is greatest in early development; testosterone is most effective in childhood, and adult treatment of true micropenis is limited and individualized.
Often saidMicropenis always means infertility or disordered sex development
ActuallyMicropenis can be isolated and idiopathic with otherwise normal function; fertility depends on the underlying cause, which is exactly why endocrine evaluation matters.
Who profits, and who pushes back
Nobody is named here yet, because we have not done that work on this entry. Read that as unfinished. Somebody almost certainly sells this, and somebody almost certainly disputes it. Assume both until we have checked.
At a glance
- Definition
- Stretched penile length more than 2.5 SD below the age mean
- Newborn threshold
- Roughly under 1.9 cm stretched (full-term)
- Adult threshold
- Roughly under 7 to 9 cm stretched
- Measurement
- Stretched length from pubic bone (fat compressed) to glans tip
- Common causes
- Hypogonadotropic hypogonadism, testicular failure, idiopathic
- First-line childhood Rx
- Testosterone (or gonadotropin) therapy
What this entry does not yet cover
What follows is unfinished work on our side, not a finding about Micropenis, Evaluation & Management. A short entry is not a safe entry.
- Timeline. We have not built the dated record of research and regulatory events.
- Cost and market. We have not documented what it sells for or who sells it.
- Supply chain. We have not mapped where it is made.
- Who uses it. We have not documented the user groups.
- What could change. No forward-looking summary yet.
- How it compares. We have not set it against the alternatives.
- Children and teenagers. We have not checked what is known about younger people.
- Where we land. We have not taken a position on this yet.
Sources
The studies below are named and described, but not linked. You cannot open them from here and check our reading against them, which means this page is our summary of the literature rather than a document you can verify. Weigh it accordingly until the links exist.
The studies that matter
Reviews of micropenis etiology, diagnosis, and treatmentvarious
Define micropenis as stretched length more than 2.5 SD below the mean with normal anatomy, classify causes into hypogonadotropic, hypergonadotropic, and idiopathic groups, and report generally promising penile-length gains with testosterone in childhood.
Studies of penile growth with hormone treatment in childrenvarious
Hormonal treatment (testosterone, and gonadotropins in selected cases) produces measurable penile growth in many children with micropenis, with response influenced by etiology and baseline morphology.